biOasis Technologies Ord Shs V.BTI.H

Primary Symbol: BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

GREY:BIOAF - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by neinsteinon Mar 03, 2014 10:53am

140 Views

Post# 22272667

RE:RE:RE:The Alias

JD. I'll give you $20 if you stop replying to that guy. The people that follow the story appreciate your contributions. As tempting as it is to consistently and constantly tell him to bugger off, seek employment and hopefully move out of his mother's basement, the constant replies only give him a reason to refrain from doing so. Show some restraint and hopefully he will go away.

Bullboard Posts

The top 5 Canadian small-cap AI stocks